Reserve entry restrictions for only the highest-risk countries.
Replace all other blanket travel restrictions with a framework of risk-based entry protocols.
Ensure the framework is easy to understand, communicate, and implement.
“The travel industry agrees that being guided by the science is absolutely the correct approach, and the science has been telling us for some time that it’s possible to begin to safely reopen international travel,” said U.S. Travel Association President and CEO Roger Dow. “Our document continues to prioritize safety while providing a roadmap for solving for the billions of dollars in economic damage resulting from the continued restrictions on crossing our borders, in particular from allied countries with similar vaccination rates. We have the knowledge and the tools we need to restart international travel safely, and it is past time that we use them.”
“U.S. airlines have been—and continue to be—strong advocates for a risk-based, data-driven approach to safely resuming international travel as laid out in the blueprint,” said Airlines for America President and CEO Nicholas E. Calio. “We have leaned into science throughout this crisis, and research has consistently determined the risk of transmission onboard aircraft is very low. In fact, the Harvard Aviation Public Health Initiative concluded that being on an airplane is as safe if not safer than routine activities such as eating in a restaurant or going to the grocery store. The science is clear—it is time, if not past the time, for the U.S. Government to take action and reopen travel between the U.S. and low-risk countries.”
The U.S. economy loses $1.5 billion each week travel restrictions remain in place, enough money to support 10,000 American jobs.
The short-term opportunities listed in the framework are:
Quickly lift entry restrictions and reopen travel between the U.S. and the United Kingdom (UK).
Quickly allow fully vaccinated individuals from non-high-risk countries to enter the U.S.
Ease entry restrictions by July 15, 2021, when the U.S. is forecast to achieve widespread immunity and sustained declines in infections and hospitalizations.
For more information, the framework is available here.